Alkermes, Inc. (NASDAQ:ALKS)

fda_logo

5 Big FDA Decisions Expected in August

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
fda_logo

5 Big Upcoming FDA Decisions Expected in July

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alibaba, Mobileye, NetApp, Nike, Salesforce.com, Stratasys and More

Stocks were marginally lower on Thursday, but investors need to keep in mind that stocks are just barely off all-time highs in the Dow and S&P. Investors keep proving over ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alkermes, Cisco, Gap, Rackspace, SouFun, Verizon and More

Stocks were getting pounded lower on Tuesday, following overseas market selling and as bonds have sold off. One thing that may bring comfort is that investors have bought stocks on ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Cisco, EMC, GameStop, Novavax, Tesla, Yahoo and More

Stocks were looking for direction on Friday morning after a choppy week. The one thing we have seen for about three years now is that investors have lined up in ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amarin, CONSOL, Garmin, GNC, HP, Peabody, Windstream and More

Stocks were indicated higher on Thursday morning after trying to find support this week. For well over two years now investors have bought stocks on each and every dip. 24/7 ...
Read Full Story »
uncertainty market evolution

5 Stocks That Will See Big Selling on Huge ETF Rebalance

All of the major money management firms that run exchange traded funds (ETFs) have to do regular quarterly rebalances to reset their portfolios to the proper allocation levels. When they ...
Read Full Story »
biotech

3 Likely Biotech Buyout Candidates

The pharmaceutical business is a difficult one, because patent expiration and competition are always omnipresent factors. Obviously major companies like to keep large research and development projects moving at full ...
Read Full Story »
Pills

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

While technology has dominated as the leading sector in the S&P 500 this year, currently up more than 20%, investors may be surprised to learn that pharmaceuticals have shown solid ...
Read Full Story »
investing

Credit Suisse Adds New Stocks in Multiple Sectors to Top Picks List

We have written before how practically all the major firms we cover have a list of top stock picks for their client base. One of the best things that a ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: J.C. Penney, Micron, Twitter, NBG, SanDisk and More

Earnings season is winding down, but investors still want to find profits and to avoid catching the top or picking bad stocks. 24/7 Wall St. reviews dozens of analyst research ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Apollo Education, Ford, GM, Alkermes, Cognizant and More

The S&P 500 hit yet another new all-time high this week, but many investors remain worried about buying the top or getting caught in a sell-off. 24/7 Wall St. reviews ...
Read Full Story »
Samuel Beckett Bridge

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

St. Patrick's Day may have come and gone for this year, but some of the biotechnology stocks that are domiciled in Ireland might just be getting ready for the party. ...
Read Full Story »
DNA

Ten Top Biotech Merger and Partnership Candidates

One of the ways the big pharmaceutical and biotechnology firms grow their business is through partnerships and acquisitions. That was never more in focus than Thursday when Pfizer lost its ...
Read Full Story »
biotech

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

The Leerink Global Healthcare conference is in full swing, and the reports coming out highlight what some top analysts on Wall Street already suspected. The rich are getting richer. With ...
Read Full Story »